Evoke plc (LON:EVOK – Get Free Report) shares dropped 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
EVOK has been the topic of a number of analyst reports. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank lowered their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th.
Get Our Latest Stock Report on Evoke
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.
Evoke Company Profile
Read More
- Five stocks we like better than Evoke
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 03/24 – 03/28
- How to Short Nasdaq: An Easy-to-Follow Guide
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- When to Sell a Stock for Profit or Loss
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.